Literature DB >> 18351289

Control of chondrogenesis by the transcription factor Sox9.

Haruhiko Akiyama1.   

Abstract

Cell-fate determination of pluripotent cells, cell proliferation, differentiation, and maturation, as well as the maintenance of stem cells, are essential cellular events during organogenesis. Previous reports show that some distinct cell-specific transcription factors are the master genes that control cell lineage commitment and the subsequent cell proliferation and differentiation. Some of these transcription factors generate hierarchical regulation of expression and act in concert to fulfill their roles. This review discusses the molecular properties and mechanisms of Sry-related high-mobility-group box (Sox) transcription factor, Sox9, in chondrogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18351289     DOI: 10.1007/s10165-008-0048-x

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  112 in total

1.  Ectopic expression of SOX9 in osteoblasts alters bone mechanical properties.

Authors:  Bojian Liang; Meghan M Cotter; Dongxing Chen; Christopher J Hernandez; Guang Zhou
Journal:  Calcif Tissue Int       Date:  2011-12-06       Impact factor: 4.333

2.  SOX9, through interaction with microphthalmia-associated transcription factor (MITF) and OTX2, regulates BEST1 expression in the retinal pigment epithelium.

Authors:  Tomohiro Masuda; Noriko Esumi
Journal:  J Biol Chem       Date:  2010-06-08       Impact factor: 5.157

3.  Fibrocartilage tissue engineering: the role of the stress environment on cell morphology and matrix expression.

Authors:  Stavros Thomopoulos; Rosalina Das; Victor Birman; Lester Smith; Katherine Ku; Elliott L Elson; Kenneth M Pryse; Juan Pablo Marquez; Guy M Genin
Journal:  Tissue Eng Part A       Date:  2011-01-09       Impact factor: 3.845

4.  Evolutionarily conserved, growth plate zone-specific regulation of the matrilin-1 promoter: L-Sox5/Sox6 and Nfi factors bound near TATA finely tune activation by Sox9.

Authors:  Andrea Nagy; Erzsébet Kénesi; Otgonchimeg Rentsendorj; Annamária Molnár; Tibor Szénási; Ildikó Sinkó; Agnes Zvara; Sajit Thottathil Oommen; Endre Barta; László G Puskás; Veronique Lefebvre; Ibolya Kiss
Journal:  Mol Cell Biol       Date:  2010-12-20       Impact factor: 4.272

5.  Lysyl oxidase-like-2 (LOXL2) is a major isoform in chondrocytes and is critically required for differentiation.

Authors:  Mussadiq Iftikhar; Paola Hurtado; Manish V Bais; Nate Wigner; Danielle N Stephens; Louis C Gerstenfeld; Philip C Trackman
Journal:  J Biol Chem       Date:  2010-11-11       Impact factor: 5.157

6.  rAAV-mediated overexpression of sox9, TGF-β and IGF-I in minipig bone marrow aspirates to enhance the chondrogenic processes for cartilage repair.

Authors:  J Frisch; A Rey-Rico; J K Venkatesan; G Schmitt; H Madry; M Cucchiarini
Journal:  Gene Ther       Date:  2015-11-19       Impact factor: 5.250

7.  Sp1 upregulates the proximal promoter activity of the mouse collagen α1(XI) gene (Col11a1) in chondrocytes.

Authors:  Keijirou Watanabe; Mariko Hida; Takako Sasaki; Hiroyuki Yano; Kenji Kawano; Hidekatsu Yoshioka; Noritaka Matsuo
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-10-20       Impact factor: 2.416

8.  Mice Deficient in NF-κB p50 and p52 or RANK Have Defective Growth Plate Formation and Post-natal Dwarfism.

Authors:  Lianping Xing; Di Chen; Brendan F Boyce
Journal:  Bone Res       Date:  2013-12-31       Impact factor: 13.567

9.  Cav3.2 T-type calcium channel is required for the NFAT-dependent Sox9 expression in tracheal cartilage.

Authors:  Shin-Shiou Lin; Bing-Hsiean Tzeng; Kuan-Rong Lee; Richard J H Smith; Kevin P Campbell; Chien-Chang Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

10.  Nuclear factor Y (NF-Y) regulates the proximal promoter activity of the mouse collagen α1(XI) gene (Col11a1) in chondrocytes.

Authors:  Mariko Hida; Ryoji Hamanaka; Osamu Okamoto; Kouhei Yamashita; Takako Sasaki; Hidekatsu Yoshioka; Noritaka Matsuo
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-10-03       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.